טוען...
Thrombolysis by chemically modified coagulation factor Xa
BACKGROUND: Enzymatic thrombolysis carries the risk of hemorrhage and re-occlusion must be evaded by co-administration with an anticoagulant. Toward further improving these shortcomings, we report a novel dual-functioning molecule, Xai-K, which is both a non-enzymatic thrombolytic agent and an antic...
שמור ב:
| הוצא לאור ב: | J Thromb Haemost |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5576980/ https://ncbi.nlm.nih.gov/pubmed/27359348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.13402 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|